Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
PF

PFE

Market Closed

Pfizer Inc.

NYSEHealthcareDrug Manufacturers - General
US
75.00K employees
CEO: Albert Bourla
Founded: 1972
$28.14
+$0.00(+NaN%)
Market Cap
160.39B
Beta
0.30
52W Range
N/A
Dividend Yield
6.11%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Pfizer’s current price implies a 9.4% upside versus a $30.83 fair value, with valuation methods showing a broad range ($17.67–$42.12), reflecting moderate uncertainty. Financial health scores suggest fair stability but limited growth and efficiency. Monte Carlo analysis indicates high volatility (52.7% CV) and notable downside risk (38.9%), highlighting investment risk amid potential upside.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore PFE

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

PFE in the Healthcare

Large Cap
Healthcare

Browse sector stocks →

Drug Manufacturers - General

Browse industry stocks →